Total investments could reach €70 million, of which approximately 15% in R&D and 85% in capex, that would be deployed from 2026
Health Secretary highlights the need for capacity building programmes for Medical Officers to tackle Non Communicable Diseases at the primary level
Authorisation will help protect adults 60 years of age and older in 30 European countries* from RSV disease for the first time
The judicial response to industry lawsuits on drug pricing regulations have been mixed in the past
The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective
Aim is to predict novel catalysts using machine learning (ML) and artificial intelligence (AI) techniques
Aim of the agreement is to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.
The Global Medical Countermeasures Platform will provide equal access safe, high-quality, cost-effective medical countermeasures to the world
Subscribe To Our Newsletter & Stay Updated
